Effect of Intravitreous Anti–Vascular Endothelial Growth Factor Therapy on Choroidal Thickness in Neovascular Age-Related Macular Degeneration Using Spectral-Domain Optical Coherence Tomography

Author(s)
Branchini, Lauren; Regatieri, Caio; Adhi, Mehreen; Flores-Moreno, Ignacio; Manjunath, Varsha; ... Show more
Thumbnail
DownloadFujimoto_Effect of intravitreous.pdf (1.219Mb)
OPEN_ACCESS_POLICY
Terms of use
Creative Commons Attribution-Noncommercial-Share Alike http://creativecommons.org/licenses/by-nc-sa/4.0/
Metadata
Show full item record
Abstract
A critical method of monitoring patients with neovascular age-related macular degeneration (AMD) being treated with anti–vascular endothelial growth factor (anti-VEGF) is optical coherence tomography (OCT), which uses low-coherence interferometry of light to examine the retina in vivo on a micrometer scale.
Date issued
2013-03
URI
http://hdl.handle.net/1721.1/86406
Department
Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science; Massachusetts Institute of Technology. Research Laboratory of Electronics
Journal
JAMA Ophthalmology
Publisher
American Medical Association
Citation
Branchini, Lauren, Caio Regatieri, Mehreen Adhi, Ignacio Flores-Moreno, Varsha Manjunath, James G. Fujimoto, and Jay S. Duker. “Effect of Intravitreous Anti–Vascular Endothelial Growth Factor Therapy on Choroidal Thickness in Neovascular Age-Related Macular Degeneration Using Spectral-Domain Optical Coherence Tomography.” JAMA Ophthalmol 131, no. 5 (May 1, 2013): 693.
Version: Author's final manuscript
ISSN
2168-6165
2168-6173
Collections